Menu
Subscribe - Individual
Subscribe - Biotech Premium (Corporate)
Home
About Us
Subscribe
Subscribe Individual
Subscribe Biotech Premium (Corporate)
Premium Biotech Coverage
Current News
Special Features
Company Index
Index Table
Summit
19th Bioshares Biotech Summit
Summit History
Contact
Contact Us
Email Alerts
Categories
Categories
Actinogen (ACW)
Adalta (1AD)
Amplia Therapeutics (ATX)
Anteris Technologies (AVR)
Aroa Biosurgery (ARX)
Blinklab (BB1)
Blog
Botanix (BOT)
Chimeric Therapeutics (CHM)
Clever Culture Systems (CC5)
Clinuvel Pharmaceuticals (CUV)
Cogstate (CGS)
Dimerix (DXB)
EBR Systems (EBR)
Immuron (IMC)
Imugene (IMU)
Island Pharmaceuticals (ILA)
Neuren Pharmaceuticals (NEU)
Patrys (PAB)
Syntara (SNT) (previously Pharmaxis, PXS)
Uncategorized
August 19th, 2022
Anteris Technologies to Move to Pivotal Study as Positive Results Continue
Read More
August 5th, 2022
Pharmaxis Sells Orbital Technology for US$5 Million
Read More
August 5th, 2022
Neuren Pharmaceuticals - Partner Files Trofinetide for US Approval
Read More
August 5th, 2022
Imricor - Europe the Key Focus
Read More
August 5th, 2022
Aroa Biosurgery - Cash Receipts up 162% for Quarter to NZ$13.9 Million
Read More
August 5th, 2022
Aroa Biosurgery - Cash Receipts up 162% for Quarter to NZ$13.9 Million
Read More
August 5th, 2022
Cogstate Annual Sales up 74% to US$82.5 Million
Read More
July 5th, 2022
Patrys Meets Manufacturing Yield Milestone for Lead Antibody Candidate
Read More
July 5th, 2022
Imugene Releases Final Survival Data in Phase II Gastric Cancer Study
Read More
June 17th, 2022
Radiopharm Theranostics In-licenses Sixth Technology Program
Read More
June 17th, 2022
Imricor Medical Systems – Pioneering MRI Assisted Cardiac Ablation
Read More
June 17th, 2022
More Important Data for Patrys
Read More
June 3rd, 2022
Radiopharm Theranostics - Six Therapeutic Studies to Commence in 2023
Read More
June 3rd, 2022
Patrys - Can Its Antibodies Prevent Metastases?
Read More
June 3rd, 2022
Dimerix - Structural Regulatory Changes in Kidney Diseases Perfect Timing
Read More
May 25th, 2022
Chimeric Antigen Receptor T Cell Therapies
Read More
May 25th, 2022
Bioshares Biotech Summit Conference Coverage - Cogstate
Read More
May 3rd, 2022
Cogstate Reports Record - Sales Up 105%
Read More
April 1st, 2022
Radiopharm Theranostics - Update
Read More
April 1st, 2022
Chimeric Therapeutics Raises $14 Million in Rights Issue
Read More
Pages
1
2
3
4
5
6
7
8
9
